Abstract:Transplantation is the most effective, and sometimes the only resort for end-stage organ failure. However, allogeneic graft suffers greatly from lymphocyte-mediated immunorejection, which bears close relationship with a hyperactivation of endoplasmic reticulum (ER) stress response in host lymphocytes, especially in CD8+ T cells (T-8). Therefore, regulating lymphocytic ER unfolded protein response (UPR) might be a potential therapeutic breakthrough in alleviating graft rejection. Here, ER-targetable liposome is prepared via the surface modification of ER-targeting peptide (Pardaxin), which efficiently loads and directly delivers small molecule inhibitor of UPR sensor IRE1α into the ER of lymphocytes, inducing a systemic immunosuppression that facilitates tumorigenesis and metastasis in the tumor inoculation challenge in vivo. And in vitro, a stage-differential dependency of IRE1α in the phase transition of T-8 is identified. Specifically, inhibiting IRE1α at the early responding stages of T-8, especially at the activation phase, results in a shrunk proliferation, impaired effector function, and limited memory commitment, which might contribute centrally to the induced overall immunosuppression. Based on this, a classical acute rejection model, murine full-thickness trunk skin allograft that primary arises from the hyperactivity of T-lymphocyte, is used. Results suggest that lymphocytic IRE1α inactivation attenuates transplant rejection and prolongs graft survival, with a limited effector function and memory commitment of host T-8. Moreover, an even higher immunosuppressive effect is obtained when IRE1α inhibition is used in combination with immunosuppressant tacrolimus (FK506), which might owe to a synergistic regulation of inflammatory transcription factors. These findings provide a deeper insight into the biological polarization and stress response of lymphocytes, which might guide the future development of allogeneic transplantation.

Elucidating the immunomodulatory effects of phytoestrogens and their groundbreaking applications in transplantation medicine

Role of IL-18 in Transplant Biology

Role of IL-33 in Transplant Biology

Gender issues in solid organ donation and transplantation.

Immune rejection: current understanding and new solutions

Advances in Innate Immunity to Overcome Immune Rejection during Xenotransplantation

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

A New Paradigm in Transplant Immunology: at the Crossroad of Synthetic Biology and Biomaterials

Cutting edge of immune response and immunosuppressants in allogeneic and xenogeneic islet transplantation

Mapping the Effect of Plant‐based Extracts on Immune and Tumor Cells from a Bioactive Compound Standpoint

Current status of xenotransplantation research and the strategies for preventing xenograft rejection

Posttransplant complications: molecular mechanisms and therapeutic interventions

Innate immune modulation in transplantation: mechanisms, challenges, and opportunities

Artemisinin Attenuates Transplant Rejection by Inhibiting Multiple Lymphocytes and Prolongs Cardiac Allograft Survival

The multifunctional roles of autophagy in the innate immune response: Implications for regulation of transplantation rejection

The Immunomodulatory Properties of Mesenchymal Stem Cells Play a Critical Role in Inducing Immune Tolerance after Liver Transplantation

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment

Adenosinergic metabolism pathway: an emerging target for improving outcomes of solid organ transplantation

Organ transplantation and gut microbiota: current reviews and future challenges

Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection

Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Potential in Organ Transplantation